Atlas Trials

A Model About the Response of Belimumab in SLE

Clinical trial NCT04893161 · UNKNOWN

Trial details

NCT number
NCT04893161
Sponsor
First Affiliated Hospital Xi'an Jiaotong University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus
Start date
2024-06-01
Primary completion
2026-01-31
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.